pharma · Generalized Pustular Psoriasis · Schizophrenia · VNDA
Vanda Pharmaceuticals Netherlands
Vanda Pharmaceuticals Netherlands B.V.
Vanda Pharmaceuticals Netherlands clinical programs — 21 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 2200 Pennsylvania Avenue NW, Suite 300E, Washington, DC 20037, US
- Founded
- 2003
- Employees
- 600
- Programs
- 60
- Drugs
- 19
- Patents
- 96
Vanda Pharmaceuticals Netherlands projects
21 ClinicalTrials.gov programs sponsored by Vanda Pharmaceuticals Netherlands.
Vanda Pharmaceuticals Netherlands has 21 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
20 mg VEC-162
Vanda Pharmaceuticals Netherlands B.V.
Insomnia
1 trial -
750 mg Imsidolimab
Vanda Pharmaceuticals Netherlands B.V.
Generalized Pustular Psoriasis
1 trial -
Double-blind 200 mg imsidolimab
Vanda Pharmaceuticals Netherlands B.V.
Generalized Pustular Psoriasis
1 trial -
Iloperidone
Vanda Pharmaceuticals Netherlands B.V.
Bipolar I Disorder
2 trials -
Milsaperidone
Vanda Pharmaceuticals Netherlands B.V.
Major Depressive Disorder (MDD)
1 trial -
Ponesimod
Vanda Pharmaceuticals Netherlands B.V.
Moderate-to-severe Chronic Plaque Psoriasis
1 trial -
Tasimelteon
Vanda Pharmaceuticals Netherlands B.V.
Jet Lag Type Insomnia
1 trial -
Tasimelteon
Vanda Pharmaceuticals Netherlands B.V.
Sleep Wake Disorders
2 trials -
Tasimelteon Oral Suspension
Vanda Pharmaceuticals Netherlands B.V.
Insomnia Disorder
1 trial -
Tradipitant
Vanda Pharmaceuticals Netherlands B.V.
Coronavirus Infection
1 trial -
Tradipitant
Vanda Pharmaceuticals Netherlands B.V.
Idiopathic Gastroparesis
2 trials -
Tradipitant
Vanda Pharmaceuticals Netherlands B.V.
Motion Sickness
4 trials -
Tradipitant
Vanda Pharmaceuticals Netherlands B.V.
Nausea and Vomiting
1 trial -
Tradipitant
Vanda Pharmaceuticals Netherlands B.V.
Atopic Dermatitis
3 trials -
VEC-162 20 mg
Vanda Pharmaceuticals Netherlands B.V.
Primary Insomnia
1 trial -
VP-VEC-162-3601
Vanda Pharmaceuticals Netherlands B.V.
Autism Spectrum Disorder
1 trial -
VP-VHX-896-3201
Vanda Pharmaceuticals Netherlands B.V.
Major Depressive Disorder
1 trial -
VQW-765
Vanda Pharmaceuticals Netherlands B.V.
Social Anxiety Disorder (SAD)
1 trial -
tasimelteon
Vanda Pharmaceuticals Netherlands B.V.
Smith-Magenis Syndrome
1 trial -
tasimelteon
Vanda Pharmaceuticals Netherlands B.V.
Non 24 Hour Sleep Wake Disorder
4 trials -
tasimelteon
Vanda Pharmaceuticals Netherlands B.V.
Major Depressive Disorder
1 trial
Frequently asked questions
How many clinical projects does Vanda Pharmaceuticals Netherlands have?
21 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.